Go to content

Orion

Feb 8th 2012
  • Suomeksi
  • Text size
  •  Home 
  • Orion
  •  Products and services 
  •  Research and development 
  •  News and media 
  •  Investors 
  •  Sustainability 
  • Careers
  • Orion in brief
  • Business environment
  • Business Divisions
    • Proprietary Products
    • Specialty Products
    • Animal Health
    • Fermion
      • APIs
      • About Fermion
      • CRAMS
      • Contacts
    • Orion Diagnostica
  • Line functions
  • Operational model
  • Partnering / Licensing
  • Strategy
  • Corporate Governance
  • General Meetings of Shareholders
  • History
  • Values
  • Orion Events Calendar
Home / Orion / Business Divisions / Fermion / From a technology perspective
Print

From a technology perspective

 

Drug Substances   

  • Technologies feasible to Fermion (lab and plant scale)
  • HAPI and their treatment classification criteria, list of classes suitable
  • Responsible Care
  • Crystallization and particle engineering

Finished Dosage Forms

  •  Finished dosage forms capabilities

Quality

  • Quality by Design
  • PAT

Regulatory Affairs 

  • List of Inspections
  • GMP Certificates

Registration

  • Drug Master Files

 Innovations

  • Patents and Publications
    •  
Updated Nov 16th 2011
Orion Corporation, Orionintie 1A, 02200 Espoo, PO Box 65, FI-02101 Espoo, Finland
Phone +358 104261 © Copyright Orion Corporation. Company code, VAT 19992126,
  • Contacts
  • About this website
  • Disclaimer
  • Sitemap
  • Feedback form